Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$423M |
| 2 |
Mettler-Toledo International
MTD
|
+$421M |
| 3 |
Capital One
COF
|
+$383M |
| 4 |
L3Harris
LHX
|
+$325M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.83B |
| 2 |
Microsoft
MSFT
|
+$1.62B |
| 3 |
Apple
AAPL
|
+$1.56B |
| 4 |
NVIDIA
NVDA
|
+$1.36B |
| 5 |
Costco
COST
|
+$731M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.97% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 9.87% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Acacia Research
ACTG
$448M
| $910K | ﹤0.01% |
254,151
+4,726
| +2% | +$16.3K |
|
3152
Talkspace
TALK
$871M
| $910K | ﹤0.01% |
327,217
+1,750
| +0.5% | +$5.16K |
|
3153
Trevi Therapeutics
TRVI
$2.63B
| $909K | ﹤0.01% |
166,265
+189
| +0.1% | +$1.18K |
|
3154
eGain
EGAN
$206M
| $906K | ﹤0.01% |
145,013
+5,329
| +4% | +$28.5K |
|
3155
SelectQuote
SLQT
$129M
| $906K | ﹤0.01% |
380,767
-9,723
| -2% | -$25.5K |
|
|
TRML
3156
DELISTED
Tourmaline Bio
TRML
| $906K | ﹤0.01% |
56,671
-4,049
| -7% | -$65.6K |
|
3157
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $905K | ﹤0.01% |
8,196
+2,580
| +46% | +$284K |
|
3158
First United
FUNC
$293M
| $903K | ﹤0.01% |
29,119
+12,871
| +79% | +$381K |
|
|
DFUS
3159
Dimensional US Equity ETF
DFUS
$21.7B
| $903K | ﹤0.01% |
13,466
-230
| -2% | -$14.2K |
|
3160
Emergent Biosolutions
EBS
$235M
| $902K | ﹤0.01% |
141,313
+124,310
| +731% | +$711K |
|
3161
Prothena Corp
PRTA
$455M
| $900K | ﹤0.01% |
148,350
+2,341
| +2% | +$17.6K |
|
|
NUTX
3162
Nutex Health
NUTX
$1.28B
| $899K | ﹤0.01% |
+7,221
| New | +$933K |
|
3163
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.96B
| $899K | ﹤0.01% |
8,562
+2,961
| +53% | +$294K |
|
3164
Delcath Systems
DCTH
$581M
| $898K | ﹤0.01% |
+66,035
| New | +$921K |
|
3165
Capricor Therapeutics
CAPR
$386M
| $897K | ﹤0.01% |
90,353
+2,633
| +3% | +$27.8K |
|
3166
PUT
Accenture
ACN
$108B
| $897K | ﹤0.01% |
3,000
| – | – |
|
3167
Equinor
EQNR
$96.8B
| $896K | ﹤0.01% |
35,648
+7,338
| +26% | +$177K |
|
3168
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.07B
| $896K | ﹤0.01% |
35,241
+1,412
| +4% | +$35.6K |
|
3169
Bioventus
BVS
$1.2B
| $895K | ﹤0.01% |
135,227
+15,178
| +13% | +$108K |
|
3170
Vodafone
VOD
$37.9B
| $892K | ﹤0.01% |
83,705
+26,260
| +46% | +$254K |
|
3171
First Bancorp
FNLC
$402M
| $892K | ﹤0.01% |
35,104
+209
| +0.6% | +$5.07K |
|
3172
Celcuity
CELC
$4.5B
| $892K | ﹤0.01% |
66,799
-1,967
| -3% | -$21.4K |
|
3173
Mobileye
MBLY
$7.58B
| $891K | ﹤0.01% |
49,580
-35,041
| -41% | -$535K |
|
3174
OraSure Technologies
OSUR
$265M
| $886K | ﹤0.01% |
295,499
-8,146
| -3% | -$23.5K |
|
3175
Inogen
INGN
$153M
| $882K | ﹤0.01% |
125,415
+934
| +0.8% | +$6.28K |
|
Similar funds
Bank of New York Mellon's Q2 2025 Portfolio in Review
As of Q2 2025, Bank of New York Mellon held 4,353 positions worth $529B, up 4.8% from $505B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon withdrew a net $22.6B in Q2 2025, closing 217 positions and reducing 1,932 holdings. Its most notable exit was Discover Financial Services, an estimated $274M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in JPMorgan Hedged Equity Laddered Overlay ETF worth $93.7M.
- Bank of New York Mellon's largest Q2 2025 buy was JPMorgan Hedged Equity Laddered Overlay ETF: 1,498,016 shares worth $93.7M.
- Bank of New York Mellon added most to Idexx Laboratories in Q2 2025, an estimated $423M increase.
- Bank of New York Mellon's biggest Q2 2025 reduction was Alphabet (Google) Class C, cutting an estimated $1.83B.
- Bank of New York Mellon fully exited Discover Financial Services in Q2 2025, selling an estimated $274M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $529B portfolio in Q2 2025.
- Bank of New York Mellon opened 243 new positions and closed 217 in Q2 2025.
- Bank of New York Mellon's portfolio value rose 4.8% quarter-over-quarter to $529B.
Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.